<DOC>
	<DOCNO>NCT00400647</DOCNO>
	<brief_summary>This study ass quality life renal transplant recipient require reduce dose mycophenolate mofetil ( MMF ) gastrointestinal ( GI ) side effect also access relationship mycophenolic acid ( MPA ) dose patient receive enteric-coated mycophenolate sodium formulation ( EC-MPS ) . Patients evaluated baseline , 2 week study medicine conversion 12 week post-conversion .</brief_summary>
	<brief_title>Gastrointestinal Health-related Quality Life Kidney Transplant Patients Treated With Mycophenolate Mofetil</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Inclusion criterion 1 . Patients recipients renal transplant . 2 . Patients treat immunosuppressive regiment include MMF recruitment . 3 . Patients suffer GI side effect relate MMF standard dose patient treat reduced MMF dose control aforementioned GI side effect . 4 . Patients 18 year old . 5 . Patients give write informed consent participate study 6 . Patients comply study requirement include complete questionnaire attend three study visit . Exclusion criteria 1 . Patients GI symptom assume know caused MPA therapy ( eg . oral bisphosphonate induce , infectious diarrhea ) 2 . Acute rejection le 1 week recruitment . 3 . Females childbearing potential pregnant , plan get pregnant and/or breast feeding willing practice approve method birth control . 4 . Presence psychiatric disorder , schizophrenia major depression , investigator 's opinion , could interfere study requirement . 5 . Patients undergo surgery due acute illness hospitalize . 6 . Existence medical condition , investigator 's opinion base anamnesis medical record , could affect study completion , include limit visual problem cognitive deterioration . 7 . Patients currently treat treat study drug treatment within 30 day prior baseline visit . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>kidney transplant</keyword>
	<keyword>enteric-coated mycophenolate sodium</keyword>
	<keyword>quality life</keyword>
	<keyword>gastrointestinal symptom</keyword>
</DOC>